Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 4Not yet recruiting 2

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Other 1

Conditions

Breast Neoplasms 4Sexual Dysfunctions, Psychological 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1

Interventions

Specimen Handling 278Magnetic Resonance Spectroscopy 233pembrolizumab 227Carboplatin 187Cisplatin 153Biopsy 148Cyclophosphamide 143Paclitaxel 133Nivolumab 122Gemcitabine 113Bevacizumab 104Radiotherapy 92Dexamethasone 86Pemetrexed 83fludarabine 77Fluorouracil 76Docetaxel 75Doxorubicin 74atezolizumab 71Radiation 71Leucovorin 70Rituximab 67Oxaliplatin 66venetoclax 61durvalumab 61Prednisone 60Vincristine 56Cetuximab 56Lenalidomide 54Etoposide 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Aromatase Inhibitors × 30 days × Clear all
NCT05879926 2026-06-03

OFSET

NRG Oncology

Phase 3 Recruiting
3,960 enrolled
Breast

Breast Neoplasms

NCT07222267 2026-06-03

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
86 enrolled
Breast

Breast Neoplasms

NCT07616427 2026-06-01

TAYLOR-003

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
100 enrolled
Breast

HR+/HER2+ Early Breast Cancer

NCT07616453 2026-06-01

TAYLOR-002

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
45 enrolled
Breast

HR+/HER2- Early Breast Cancer

NCT07618923 2026-06-01

TD-DASHER-01

Tang-Du Hospital

Phase 2 Not yet recruiting
20 enrolled
Breast

Breast Neoplasms

NCT07596212 2026-05-19

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

University of Illinois at Chicago

Phase 1/2 Not yet recruiting
100 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡